1. Pharma industry's reputation hits plateau — Biogen looks to build better gene therapies through latest deal — Lilly enlists a long-incubating RNA upstart in new $1.25B partnershipSee more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

key opinion leaders

Discussion in 'Podiatry' started by Anonymous, Aug 11, 2012 at 4:08 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Who are the major key opinion leaders in the world of offloading therapies/devices for diabetic neuropathy?

  2. Anonymous

    Anonymous Guest

    Alexander Reyzelman in the Bay Area is well respected and Guido Laporta in NY is also well known. Both are very active in Podiatry education and residency training.